Industry weighs into German healthcare reform debate with new study highlighting value of devices
This article was originally published in Clinica
Executive Summary
A new industry-commissioned report to be published this week in Germany makes a series of policy recommendations to ensure that patients have unimpeded access to "reasonable and necessary" medical devices and that innovative technologies are introduced into the health system without avoidable delays. It refers among other things to German government plans to introduce a comprehensive hospital reimbursement system based on diagnosis-related groups (DRGs) in 2003.